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OA. There was no difference in the range of knee extension between those
with PFJ OA and those with no OA, but participants with PFJ OA performed
signiﬁcantly worse on functional tests than those who were free of OA
Conclusions: PFJ OA is relatively common ∼7 years after HT ACLR and is
associated with worse symptoms and reduced functional performance
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Purpose: We developed a novel lateral wedged insole with elastic ﬁx-
ation of the subtalar joint (the strapped insole) for patients with knee
osteoarthritis (OA) to correct the femorotibial angle, this limitation of the
traditional inserted insoles. However, the strapped insole of the knee had a
limitation in that it was diﬃcult to improve knee pain with ambulation on
uneven ground. In order to solve this limitation of the strapped insole, we
considered adding a knee orthotic device to the insole. Therefore, this study
was designed to evaluate the eﬃcacy and compliance of knee orthotic
devices as assistance for the strapped insole.
Methods: The 110 knee OA patients were prospectively randomized and
treated with one of the following interventions: a strapped insole alone
(the control group, n=37), the strapped insole combined with a relatively
long elastic knee sleeve (the plus long sleeve group, n=36), or the insole
plus a short sleeve (the plus short sleeve group, n=37). In the course of
the four-week study, every participant could propose quitting the allocated
orthotic device for any discomfort.
Results: In the 93 patients that completed the study, the mean values
and standard deviations for changes in the Lequsne index at the ﬁnal
assessment, compared with the baseline assessment, were -4.8±5.2 in
the control group, -4.0±4.7 in the plus long sleeve group, and -4.7±6.2
in the plus short sleeve group. Participants wearing the strapped insole
alone (P<0.0001), the strapped insole with long sleeve (P=0.0001) and
the strapped insole with short sleeve (P<0.0001) demonstrated signiﬁ-
cantly improved Lequesne index values in comparison with their baseline
assessments. The number of participants that could walk without knee
pain on uneven ground was signiﬁcantly increased at the ﬁnal assessment
compared with that at the baseline assessment in the plus long and short
sleeve groups (P=0.005 and 0.002, respectively), but not in the control
group (P=0.32). The frequency of withdrawal was more common in the
plus long sleeve group (13/36, 36.1%) than in the control (1/37, 2.7%) or the
plus short sleeve groups (3/37, 8.1%).
Conclusions: In the plus long and short sleeve groups, the number of
participants that could walk easily on uneven ground was increased at
the ﬁnal assessment compared with that at the baseline assessment. These
results suggested that an elastic knee sleeve, when combined with use
of the strapped insole, was useful to prevent the increased pain due to
ambulation on uneven ground. For compliance, the short sleeve may be
more comfortable than the long sleeve as an assistant knee sleeve for the
strapped insole.
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Purpose: The aim of this study was to evaluate the transdermal permeation
of Hialsorb® in the presence/absence of ultrasound. Hialsorb® is a ﬂuid
emulsion for joint massage that contains 0.25% of hyaluronic acid and 0.25%
of other mucopolysaccarides.
Phonophoresis or sonophoresis is the use of ultrasound to increase
percutaneous absorption of a drug. Recent studies have shown that
ultrasound-mediated transdermal drug delivery offers a promising poten-
tial for noninvasive drug administration.
Methods: The transdermal permeation of the mucopolysaccharides present
in Hialsorb® was studied in vitro with human skin from the abdomen
of healthy women who underwent cosmetic surgery (0.4 mm thick). The
transdermal permeation was determined in natural conditions (Experiment
1) and also after the application of ultrasound (Experiments 2 and 3). Skin
samples from 7 healthy donors were used and barrier integrity of the skin
was characterized by transepidermal water loss (Tewl) measurements. We
used Franz-type vertical diffusion cells with an effective permeation area
of approximately 13 ml (17 ml for experiments 2 and 3). The formulation
studied (0.3g-0.8g) was placed in the donor compartment and the receptor
chamber was ﬁlled with PBS (phosphate-buffered saline, pH 7.4) and
kept at 37±0.5 °C. In experiments 2 and 3 we treated samples with the
ultrasound device for 15 minutes under 2 different conditions, 1 W/cm2
continuous mode and 2.4 W/cm2 pulsed mode (1:4), respectively. This
approach corresponds to a simultaneous application of drug and ultrasound
to the skin. Samples of 400 μl were withdrawn from the receptor compart-
ment during 24 hours. The determination of the glycosaminoglycans was
done by means of a colorimetric assay. The ultrasound device used was
MEGASONIC 700 (Ultrasound 1-3 MHz, Electromedicarin S.A.).
Results: The study shows that the degree of permeation of Hyaluronic Acid
and other mucopolysaccharides (expressed as total glycosaminoglycans)
through the skin of 6 different donors and from the emulsion called
Hialsorb® at 24 h was approximately 17%. We have found an increase
in the permeation of glycosaminoglycans compared to its corresponding
control condition of 9.93% for experiment 2 and 11.62% for experiment 3.
Conclusions: The experiments performed have demonstrated that ther-
apeutic ultrasound (1-3 MHz) is able to increase by around 10% the
permeation of the glycosaminoglycans present in Hialsorb®, therefore top-
ical application of the formulation is suitable for ultrasound transmission,
to enhance the effects of physiotherapy and speed up functional recovery.
This emulsion is an effective treatment for knee pain caused by joint-
cartilage loss and/or soft-tissue injuries such as tendinosis and bursitis,
when diagnosed by ultrasound.
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Purpose: To describe the feasibility of a progressive twelve-week neu-
romuscular and strength training program in middle-aged patients with
degenerative meniscus tear by the use of a single case report. Feasibility
was determined as 1) acceptable self-reported pain during the program, 2)
decreased pain throughout the program, 3) improved knee muscle strength,
4) improved physical performance, and 5) improved global rating of knee
function.
Methods: A 51-year-old man (1.73m, 80kg) with unilateral degenerative
meniscus tear included in an ongoing randomized controlled trial, com-
pleted a twelve-week progressive neuromuscular and strength training
program. The program included standardized progressive muscle strength
training and neuromuscular exercises performed two to three times per
week for 12 weeks. The principles and progression were in accordance
with current American College of Sports Medicine guidelines in terms of
frequency, volume and recovery time for recreational athletes at a novice
and intermediate level. Single and multiple joint exercises, open and closed
kinetic chain, as well as concentric and eccentric exercises were included.
Single leg exercises on balance pads and variations of single-leg hops were
included to maintain neuromuscular performance. Pain was self-reported
during and immediately after each training session by a visual analogue
scale (VAS) from 0-10, where 0 to 2 indicated no or minimal pain, >2 to 5
some pain, and >5 high levels of pain. Level 0-5 was deﬁned as acceptable
levels of pain. Levels of pain week one were compared to levels of pain
week 12, in order to evaluate pain throughout the program. Isokinetic
quadriceps and hamstrings strength (60°/sec) were evaluated before and
after the program and presented in percent difference between legs for
peak torque (PT) and total work (TW). Physical performance was evaluated
by two single-leg hop tests: the one-leg hop for distance (OLH) and the
6-meter timed hop test (6MTH). Percent difference between legs before and
after the program is presented. Global rating of knee function was recorded
